Table 2.
List of antidepressant, antipsychotic, and mood‐stabilizing medication in the two patient samples
| Number of unipolar patients | Number of bipolar patients | |
|---|---|---|
| Antidepressive medication | 18 | 13 |
| Agomelatine | 3 | 0 |
| Amytriptyline | 1 | 0 |
| Bupropion | 1 | 0 |
| Citalopram | 2 | 2 |
| Doxepin | 1 | 0 |
| Duloxetin | 1 | 1 |
| Escitalopram | 1 | 2 |
| Fluoxetine | 1 | 0 |
| Mirtazapin | 3 | 5 |
| Nortriptyline | 0 | 1 |
| Sertraline | 1 | 2 |
| Tranylcypromine | 0 | 1 |
| Venlafaxine | 7 | 3 |
| Antipsychotic medication | 10 | 15 |
| Amisulpride | 1 | 0 |
| Asenapine | 0 | 1 |
| Olanzapine | 1 | 1 |
| Pipamperone | 2 | 0 |
| Promethazine | 1 | 0 |
| Quetiapine | 6 | 14 |
| Mood stabilizer | 3 | 13 |
| Lamotrigine | 1 | 3 |
| Lithium | 2 | 9 |
| Valproic acid | 0 | 3 |
Values reflect number of patients treated with the respective medication. Due to combination treatments, the number of single substances within each medication class can exceed the number of patients treated with the respective medication class.